r google-plus facebook twitter linkedin2 nujij P P M G W Monitor Nieuwsbrief pdclogo man met tas twitter boek

250 Million EUR Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference, Den Haag

Ridderzaal in Den Haag
© Kevin Bergenhenegouwen
datum 24 oktober 2019 - 25 oktober 2019
plaats Den Haag
organisatie Gemeenschappelijke Informatiedienst Onderzoek en Ontwikkelingen (CORDIS)

Neuronet Public Event Features Major European Research Projects on Alzheimer's Disease and Beyond During the Alzheimer Europe Conference 2019 in The Hague, taking Place on 24-25 October.

In recent years, European research projects have brought many crucial stakeholders together. Four Neuronet sessions, as part of the Alzheimer Europe Conference, will provide insights from research projects that have been launched by the Innovative Medicines Initiative (IMI), Europe's biggest public-private partnership in the life sciences.

The Neuronet sessions will introduce the IMI and its neurodegeneration portfolio. The programme is listed below:

Thursday, 24 October, 10.30-12.00

Parallel session P5. European research collaboration in Alzheimer's disease and beyond

The Innovative Medicines Initiative and its neurodegeneration portfolio

Neuronet - Efficiently Networking European Neurodegeneration Research

Patient and Public Involvement in the IMI research portfolio

Thursday, 24 October, 14.00-15.30

Parallel session P13. From risk to dementia - Understanding disease progression and its causes

ADAPTED - Alzheimer's disease apolipoprotein pathology for treatment elucidation and development

PHAGO - Targeting TREM2 and CD33 of phagocytes for treatment of Alzheimer's disease

AETIONOMY - Disease Mechanisms for Patient Subgroup Identification and Disease Progression Modeling

Friday, 25 October, 10.30-12.00

Parallel session P21. Improving data access and the development of predictive models

EQIPD - Data quality in preclinical research

EMIF - European Medical Information Framework

ROADMAP - Real world outcomes across the AD spectrum

IM2PACT - Discovery of blood-brain barrier targets and transport pathways to treat neuro/metabolic diseases - A public-private partnership

Friday, 25 October, 14.00-15.30

Parallel session P29. Diagnosis, patient engagement and trials

AMYPAD - Amyloid imaging to prevent Alzheimer's disease

EPAD - European prevention of Alzheimer's dementia consortium

MOPEAD - Models of Patient Engagement in Alzheimer's Disease: a European project to develop and test innovative patient engagement strategies

RADAR-AD - Remote Assessment of functional decline in Alzheimer's Disease

For more information visit: https://www.imi-neuronet.org/2019-event-the-hague/


Inhoud

1.

Gemeenschappelijke Informatiedienst Onderzoek en Ontwikkelingen (CORDIS)

De Gemeenschappelijke Informatiedienst Onderzoek en Ontwikkelingen (CORDIS) houdt zich bezig informatieverstrekking over Europese onderzoeksactiviteiten in het kader van onderzoek en ontwikkeling en het verspreiden van technische kennis en toepassingen binnen de EU.

CORDIS heeft als doel:

  • deelname aan Europees onderzoek faciliteren en stimuleren
  • het verbeteren van de exploitatie van onderzoeksresultaten in het kader van een competitief Europa (zie ook Zevende Kaderprogramma)
  • de praktische toepassing van technologisch onderzoek door bedrijven stimuleren door de verspreiding van kennis
  • het bevorderen van de verspreiding van technologische kennis om de sociale acceptatie van nieuwe technologie te stimuleren

2.

Meer over...

Terug naar boven